CM
ACAD icon

CM Management’s Acadia Pharmaceuticals ACAD Stock Holding History

CM Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,000
Closed -$1.25M – 68
2025
Q1 		$1.25M Buy
75,000
+5,000
+7% +$90.8K 1.25% 35
2024
Q4 		$1.28M Hold
70,000
– – 1.15% 34
2024
Q3 		$1.08M Buy
70,000
+30,000
+75% +$500K 0.86% 42
2024
Q2 		$650K Hold
40,000
– – 0.6% 48
2024
Q1 		$740K Buy
40,000
+10,000
+33% +$248K 0.62% 49
2023
Q4 		$939K Buy
+30,000
New +$716K 0.75% 41

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return